| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 03/13/2002 | EP1185236A2 Compositions for dyeing keratinic fibres, containing paraphenylenediamine derivatives with an azetidinyl group |
| 03/13/2002 | CN1339433A Process for chloridizing dithio-aza cyclo-butanone derivatives |
| 03/07/2002 | WO2002018432A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/07/2002 | US20020028835 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 03/07/2002 | US20020028821 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 03/07/2002 | CA2420652A1 Vertebrate intestinal protein which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/06/2002 | EP1183262A1 Intermediates for and synthesis of 3-methylene cephams |
| 03/06/2002 | EP1183238A1 Metabotropic glutamate receptor antagonists |
| 03/06/2002 | EP1183235A2 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | CN1080256C Beta-lactams, methods for preparation of taxanes and sidechain-bearing taxanes |
| 02/27/2002 | EP1181273A1 New process |
| 02/27/2002 | EP0792264B1 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 02/26/2002 | US6350887 Chemical intermediates for anticarcinogenic agents |
| 02/26/2002 | US6350886 Anticarcinogenic agents |
| 02/26/2002 | US6350883 Method for preparing lactam |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/21/2002 | WO2002014270A1 New amidino derivatives and their use as thrombin inhibitors |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | US20020022612 Nitrogen containing heterocyclic compounds useful as anticoagulants |
| 02/21/2002 | US20020022605 Cyclamine sulfonamides as beta-3 adrenergic receptor agonists |
| 02/20/2002 | EP1180098A1 New compounds |
| 02/14/2002 | WO2002012230A1 Intermediate of carbapenem antibiotics and process for the preparation thereof |
| 02/14/2002 | WO2002012187A1 Novel phenylheteroazetidines, useful as nitric oxide synthase inhibitors |
| 02/14/2002 | US20020019540 Conformationally constrained compounds as pharmaceutical agents |
| 02/14/2002 | US20020019539 Antiarthritc agents; anticancer agent |
| 02/14/2002 | US20020019383 3-amido or 3-sulfonylamino azetidine compounds and their preparation; high affinity for cannabinoid receptor CB1 type, useful in treating central nervous system, immune, gastrointestinal or cardiovascular disorders, drug abuse |
| 02/14/2002 | US20020019371 Use as anticoagulants; competitive inhibitors of thrombin; for example, 1-(phenyl-2-hydroxyethane-1,1-diylcarbonyl), 2-((4-amidinophenyl)- alkylaminocarbonyl)azetidine |
| 02/13/2002 | EP0869942B1 4-((heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
| 02/12/2002 | CA2221190C Novel substituted taxanes and pharmaceutical compositions containing them |
| 02/12/2002 | CA2067877C Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present |
| 02/07/2002 | US20020016337 Heterocyclic analgesic compounds and methods of use thereof |
| 02/06/2002 | CN1334726A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists |
| 01/31/2002 | US20020013501 By Reformatsky rearrangement of aldehydes, ketones, or imines in presence of zinc |
| 01/31/2002 | DE10035144A1 Cyclische Aminosäurederivate Cyclic amino acid derivatives |
| 01/24/2002 | WO2002006232A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 01/24/2002 | WO2002006221A2 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 01/24/2002 | US20020010348 Methods for preparing new taxoids and pharmaceutical compositions containing them |
| 01/24/2002 | US20020010343 Compounds having IgE affecting properties |
| 01/24/2002 | CA2416667A1 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 01/24/2002 | CA2416245A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 01/23/2002 | CN1332737A Thrombin inhibitors |
| 01/22/2002 | US6340751 Reaction of imidazolone with amide and magnesium compound |
| 01/22/2002 | CA2061577C Process for the preparation of chiral 4-aryloxyazetidinones |
| 01/17/2002 | WO2002004402A1 Ester derivatives |
| 01/17/2002 | US20020006920 Arylsulfonylamino hydroxamic acid derivatives |
| 01/17/2002 | DE10031604A1 Verfahren zur Herstellung von beta-Hydroxy- und beta-Aminocarbonylverbindungen A process for preparing beta-hydroxy and beta-amino carbonyl compounds |
| 01/17/2002 | CA2415468A1 Ester derivatives |
| 01/10/2002 | WO2002002522A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | CA2414464A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/09/2002 | EP1170287A1 Process for preparation of optically active n-substituted azetidine-2-carboxylic acids |
| 01/09/2002 | EP1169468A1 Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(r)-[3(s)-hydroxy-3-(4-fluorophenyl)propyl)]-4(s)-(4-hydroxyphenyl)-2-azetidinone |
| 01/09/2002 | CN1330721A Resolution of trans-2-(alkoxycarbonylethyl)-laitams useful in synthesis of 1-(4-fluorophenyl)-3(R)-[3(s)-hydroxy-3-(flurophenyl)-propyl)]-4(s)-(4-hydroxyphenyl)-2-azetidinone |
| 01/08/2002 | US6337343 Amino acid derivatives |
| 01/08/2002 | CA2205202C Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 01/08/2002 | CA2159450C 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors |
| 01/03/2002 | US20020002292 C7 taxane derivatives and pharmaceutical compositions containing them |
| 01/02/2002 | EP1167325A1 Process for preparing hydroxy and amino compounds |
| 01/02/2002 | EP1165507A1 Biocatalyst and its use in enzymatic resolution of racemic beta-lactams |
| 01/02/2002 | EP1165506A1 Substituted azetidin-2-ones as cysteine protease inhibitors |
| 01/02/2002 | CN1329592A Process for synthesis of beta-propanamide |
| 01/01/2002 | US6335362 Antitumor and anticarcinogenic agents for leukemia |
| 01/01/2002 | US6335324 Treating asthma or allergic rhinitis |
| 12/25/2001 | US6333418 Cyclization of 4-amino-2-halobutyric acid to azetidine-2-carboxylic acid wherein more than 30 g of acid is cyclized per liter of reaction mixture |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | WO2001041724A3 Compositions for dyeing keratinic fibres, containing paraphenylenediamine derivatives with an azetidinyl group |
| 12/19/2001 | CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/18/2001 | CA2078684C Process for preparing penem esters |
| 12/12/2001 | EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 12/11/2001 | CA2166784C Process for the synthesis of azetidinones |
| 12/06/2001 | WO2001092226A1 Heterocyclic analgesic compounds and method of use thereof |
| 12/06/2001 | US20010049367 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
| 12/05/2001 | EP0911327B1 Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient |
| 11/29/2001 | US20010047031 Heterocyclic compounds useful as NMDA receptor selective subtype blockers |
| 11/28/2001 | EP0690712B1 Taxanes having a pyridyl substituted side-chain |
| 11/21/2001 | EP0641328B1 Bridged aza-bicyclic derivatives as substance p antagonists |
| 11/21/2001 | CN1075066C Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
| 11/14/2001 | EP0686613B1 Ozonide reducing agent |
| 11/13/2001 | US6316638 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 11/07/2001 | EP1150996A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 11/07/2001 | EP0592677B1 Beta-LACTAM COMPOUND AND CEPHEM COMPOUND, AND PRODUCTION THEREOF |
| 11/06/2001 | US6313315 Methods for producing N-protected-azetidine-2-carboxylic acids |
| 11/06/2001 | US6313307 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings |
| 11/01/2001 | WO2001081303A1 Pyrrolidine and piperidine derivatives and their use for the treament of neurodegenerative disorders |
| 11/01/2001 | US20010037020 Method for preparation of taxol |
| 10/30/2001 | US6310201 (3r-cis)-1-benzoyl-3-(1-methoxy-1-methylethoxy)-4-phenyl-2-aze tidinone. |
| 10/30/2001 | US6310095 Inhibitors of protein isoprenyl transferases |
| 10/24/2001 | EP1148055A1 C9 taxane derivatives and pharmaceutical compositions containing them |
| 10/24/2001 | EP0856002B1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings |
| 10/18/2001 | WO2001077073A1 Cathepsin cysteine protease inhibitors |
| 10/18/2001 | WO2000071518A3 Heterocyclic analgesic compounds and their use |
| 10/18/2001 | CA2404630A1 Cathepsin cysteine protease inhibitors |
| 10/17/2001 | EP1146043A1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
| 10/17/2001 | CN1317965A Compounds having IgE affecting properties |
| 10/16/2001 | US6303636 Arylsulfonylamino hydroxamic acid derivatives |
| 10/10/2001 | EP1140918A1 Thrombin inhibitors |
| 10/10/2001 | EP1140820A1 New amidino derivatives and their use as thrombin inhibitors |
| 10/10/2001 | EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 10/10/2001 | EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
| 10/10/2001 | CN1316991A Azetidine derivatives, preparation and medicines containing them |
| 10/10/2001 | CN1072666C (Azetidin-1-ylalkyl) lactams as tachykinin antagonists |